NCT03902301 - Lactobacillus Rhamnosus and PCOS Treatment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Insulin ResistancePolycystic Ovary SyndromeHyperandrogenismObesity

Interventions

DIETARY_SUPPLEMENT

Lactobacillus group

Nutrition intervention focused on the treatment of insulin resistance + Lactobacillus rhamnosus supplementation (6x10 9 of lactobacillus rhamnosus x 2 times a day) (35 people).

DIETARY_SUPPLEMENT

Dietary group

Nutritional intervention focused on the treatment of insulin resistance (35 subjects).

Trial Locations (1)

60-624

Poznan University of Life Sciences, Poznan

All Listed Sponsors

lead

Poznan University of Life Sciences

OTHER